
Publikationen von Matthias Knop
Alle Typen
Zeitschriftenartikel (19)
1.
Zeitschriftenartikel
Subcortical Volumes as Early Predictors of Fatigue in Multiple Sclerosis. ANNALS OF NEUROLOGY (2022)
2.
Zeitschriftenartikel
7 (5), e827 (2020)
Genetic determinants of the humoral immune response in MS. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION 3.
Zeitschriftenartikel
266 (2), S. 386 - 397 (2019)
Can we predict cognitive decline after initial diagnosis of multiple sclerosis? Results from the German National early MS cohort (KKNMS). JOURNAL OF NEUROLOGY 4.
Zeitschriftenartikel
2 (6), e1501678 (2016)
Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation. SCIENCE ADVANCES 5.
Zeitschriftenartikel
39 (8), S. 601 - 608 (2015)
Successful Replication of GWAS Hits for Multiple Sclerosis in 10,000 Germans Using the Exome Array. GENETIC EPIDEMIOLOGY 6.
Zeitschriftenartikel
8 (404), S. ra119 - ra119 (2015)
Chaperoning epigenetics: FKBP51 decreases the activity of DNMT1 and mediates epigenetic effects of the antidepressant paroxetine. Science signaling 7.
Zeitschriftenartikel
130 (1), S. 46 - 52 (2014)
Interferon-1a reduces increased interleukin-16 levels in multiple sclerosis patients. ACTA NEUROLOGICA SCANDINAVICA 8.
Zeitschriftenartikel
259 (Suppl. 1), S. S13 - S13 (2012)
Methylprednisolone-regulated genes affecting multiple sclerosis pathogenesis. Journal of Neurology 9.
Zeitschriftenartikel
123 (6), S. 400 - 406 (2011)
More CLEC16A gene variants associated with multiple sclerosis. Acta Neurologica Scandinavica 10.
Zeitschriftenartikel
227 (1-2), S. 162 - 166 (2010)
Evidence for VAV2 and ZNF433 as susceptibility genes for multiple sclerosis. Journal of Neuroimmunology 11.
Zeitschriftenartikel
81 (Suppl. 1), S. 18 - 19 (2010)
USPIO-gestützte Charakterisierung der weißen Substanz bei MS. Nervenarzt 12.
Zeitschriftenartikel
257 (Suppl. 1), S. S218 - S219 (2010)
Modulation of interleukin-16 by interferon beta-1a treatment in patients with multiple sclerosis. Journal of Neurology 13.
Zeitschriftenartikel
80 (Suppl. 1), S. 12 - 13 (2009)
Nachweis der Anreicherung von "Ultra Small Particles of Iron Oxide" in MS-Läsionen. Nervenarzt 14.
Zeitschriftenartikel
14 (Suppl. 1), S. S132 - S132 (2008)
Prohibitin: prohibiting inflammation in glatiramer acetate-treated multiple sclerosis patients? Multiple Sclerosis 15.
Zeitschriftenartikel
255 (Suppl. 2), S. 52 - 53 (2008)
IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations. Journal of Neurology 16.
Zeitschriftenartikel
9 (3), S. 259 - 263 (2008)
IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations. Genes and Immunity 17.
Zeitschriftenartikel
40 (5), S. 245 - 245 (2007)
Protein expression profiling of human glatiramer acetate (GA) and myelin basic protein (MBP) specific T cell lines from a multiple sclerosis (MS) patient and healthy donors. Pharmacopsychiatry 18.
Zeitschriftenartikel
254 (Suppl. 3), S. 189 - 190 (2007)
Protein expression profiling of human glatiramer acetate specific T cell lines from a multiple sclerosis patient and healthy donors. Journal of Neurology 19.
Zeitschriftenartikel
254 (Suppl. 3), S. 73 - 73 (2007)
Human antigen specific T cell lines express neurturin, a member of the GDNF family ligands. Journal of Neurology Meeting Abstract (3)
20.
Meeting Abstract
30 (3), S. 308 - 309. 40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Copenhagen, DENMARK, 18. September 2024 - 20. September 2024. (2024)
Cytokines associated with disability progression over one year in a German monocentric MS cohort. In MULTIPLE SCLEROSIS JOURNAL,